Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-483-1 | CAS number: 616-45-5
Neurotoxicity
Administrative data
Description of key information
Summary of literature data.
Key value for chemical safety assessment
Additional information
Several special investigations in animals have been conducted to evaluate the neurotoxicity potential of 2-pyrrolidone.
In one study, 2-pyrrolidone was applied intravenously in a single dose to mice (Hawkins and Sarett, 1957). Control animals received vehicle on the same routes. No antivconvulsive effects were observed against elektro-shock induced convulsions. Interestingly convulsions induced by beta-methyl-beta-ethylglutarimide or pentylenetetrazole were effected and the anticonvulsive ED50 was 150 and 200 mg/kg bw respectively. Another study revealed a tranquilising potential of 2 -pyrrolidone (Siroslawska, 1965). Mice, rats, rabbits, cats or guinea pigs which received intraperitoneally 2 -pyrrolidone exhibited significant slower movements, a reduced ability for coordination and a reduced spontaneous activity in the brain.
The youngest study available dealt with the investigation whether analogons of 4-hydroxy butyric acid and butyrolacton would affect the balance reaction, and revealed that they did not influence the rightening reflex in rats (Markus et al., 1976). Beside that the study revealed a desynchronisation in the EEG after administration of the analogons.
Lightowler et al. investigated 1963 in mice, whether 2-pyrrolidone had anti-strychnine activities (Lightowler et al., 1963). The study revealed that 2-pyrrolidone had anti-strychnine activity at 875 and 1750 mg/kg but not at higher doses.
Justification for classification or non-classification
Classification is not warranted according to the criteria of EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
